How many insider disclosures are linked to Autonomix Medical, Inc.?

Available records link 3 public disclosures to Autonomix Medical, Inc., sourced from SEC (Form 4).

Who is the top reporting insider at Autonomix Medical, Inc.?

The top reporting insider at Autonomix Medical, Inc. is Hauser Bradley, based on the count of public filings.

What declared insider buy and sell totals are available for Autonomix Medical, Inc.?

Across the available history, declared buys total 0 and disposals 0.

← Companies ★ Sign in to follow

AM

Autonomix Medical, Inc. Stock: price and management transactions · United States · SEC (Form 4)

Source idSEC:autonomix-medical-inc-c7db29·SEC (Form 4)

SEC (Form 4)

Follow the Autonomix Medical, Inc. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). The latest transaction was disclosed on 8 September 2026 (Attribution). Among the most active insiders: Hauser Bradley. All data is openly available.

3

Insider Decl.

n/a

Thresholds

n/a

Buy Volume

n/a

Sell Volume

Sigma AI Analysis

Fundamental view, insider signal, bull and bear case, synthesis.

AI analysis generation is paused.

Last declaration on 8 September 2026

Declarations3 total

◆

Hauser Bradley

CEO and PresidentExecutives3 Sept 2026

0SEC ↗

27,000 sharesCommon StockSEC:0001437749-26-029830:0

◆

Bisson Lori

DirectorExecutives3 Sept 2026

0SEC ↗

13,000 sharesCommon StockSEC:0001437749-26-029833:0

◆

KLEMP WALTER V

DirectorExecutives3 Sept 2026

0SEC ↗

13,000 sharesCommon StockSEC:0001437749-26-029835:0

3 of 3 declarations

InsidersTradesSigma

← Companies ★ Sign in to follow

AM

Autonomix Medical, Inc. Stock: price and management transactions · United States · SEC (Form 4)

Source idSEC:autonomix-medical-inc-c7db29·SEC (Form 4)

SEC (Form 4)

Follow the Autonomix Medical, Inc. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). The latest transaction was disclosed on 8 September 2026 (Attribution). Among the most active insiders: Hauser Bradley. All data is openly available.

3